Trials / Unknown
UnknownNCT01687647
Sputum Cytometry Analysis in Lung Cancer Screening After Professional Asbestos Exposure
Interest of Morphometric Analysis of Sputum Cytology for Lung Cancer Screening in Workers Highly Exposed to Asbestos - Exploratory Analysis of Biomarkers Predictive for Lung Cancer
- Status
- Unknown
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 1,000 (estimated)
- Sponsor
- University Hospital, Caen · Academic / Other
- Sex
- All
- Age
- 56 Years
- Healthy volunteers
- Not accepted
Summary
Workers exposed to asbestos are at high risk of lung cancer. Medical follow-up of this population relies on repeated CT-scans which are more accurate for detection of peripheral lesions, and expose to X-rays and to risk of false-positives. Analysis of sputum using automate cytometry may be of interest in this population, alone or in combination with CT-scan. An ancillary study will evaluate the interest of blood predictive biomarkers.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | low-dose CT-scan AND induced sputum sample AND blood test | All subjects will receive a low-dose CT-scan, a blood test (ancillary study) and provide an induced sputum |
Timeline
- Start date
- 2012-09-01
- Primary completion
- 2015-03-01
- Completion
- 2019-12-01
- First posted
- 2012-09-19
- Last updated
- 2014-04-09
Locations
3 sites across 1 country: France
Source: ClinicalTrials.gov record NCT01687647. Inclusion in this directory is not an endorsement.